Clinical Trial of Approaches to Prostate Cancer Surgery
for
Prostate Cancer
Location: Boston MA, Flushing NY, New York NY, Hackensack NJ,
Sponsor: Weill Medical College of Cornell University
Sex: Male
Age: 40 - 70+
Code: NCT05155501
Recruiting
The SUGAR Study; SBRT and Relugolix) for Prostate Cancer
for
Prostate Cancer
Location: New Haven CT, New York NY, Seattle WA
Sponsor: Yale University
Sex: Male
Age: 18+
Code: NCT06111781
Phase2, Recruiting
Comparing Moderately Ultra Hypofractionated Radiation Treatments for Prostate Cancer
for
Post-Operative Prostate Cancer
Location: Toronto, London
Sponsor: University Health Network, Toronto
Sex: Male
Age: 18+
Code: NCT06409910
Phase2, Recruiting
Impact of Hormonal Therapy on Prostate Cancer Recurrence After Radical Prostatectomy
for
Prostate Cancer
Location: Halifax, Ottawa
Sponsor: Ottawa Hospital Research Institute
Sex: Male
Age: 18+
Code: NCT05169112
Phase3, Recruiting
LIVInG With chrONic Cancer TrEatments (LONGEVITI) Study
for
Cancer, Tyrosine Kinase Mutation, Breast Cancer, Melanoma,
Location: Edmonton
Sponsor: University of Alberta
Sex: All
Age: 18 - 70+
Code: NCT05645510
Recruiting
Using MRI to Identify Areas to Receive Lower Doses of Radiation Treatment in Men With Prostate Cancerdose Mapping to Preserve Quality of Life
for
Prostate Cancer
Location: Chicago IL
Sponsor: University of Chicago
Sex: Male
Age: 18+
Code: NCT06171269
Recruiting
Erectile Recovery After Robotic-Assisted Laparoscopic Prostatectomy
for
Erectile Dysfunction, Prostate Cancer
Location: San Antonio TX
Sponsor: Brooke Army Medical Center
Sex: Male
Age: 30 - 70+
Code: NCT03406169
Phase3, Recruiting
Substudy 01A: Safety and Efficacy of Opevesostat (MK-5684)-Based Treatment Combinations or Opevesostat Alone in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-01A)
Nutrition and Exercise Interventions for Androgen Deprivation Therapy-Induced Obese Frailty in Elderly and Non-Elderly Survivors of Advanced Prostate Cancer
for
Cancer Survivor, Obesity, Overweight, Prostate Adenocarcinoma,